SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?


To: AHM who wrote (984)7/25/1998 12:20:00 PM
From: billkirn  Respond to of 1510
 
AHM: This stock looks like it has broken down. I sold my shares in the 11.5 area and took my loss. I will put these resources in AGPH since it gets the benefits of Remune and has sound and serious income with Viracept. AGPH has also obtained a great pipeline in the HIV area and is making some moves that should improve the perception and value of its stock.
Bill



To: AHM who wrote (984)7/26/1998 2:30:00 PM
From: Robert DeHaven  Respond to of 1510
 
I agree...good traders will do this. I think the time to do that trade was at 16+ now the upside far outweighs any reward on the downside....aka too much risk shorting imnr down here...IMHO.

bob



To: AHM who wrote (984)7/29/1998 10:47:00 AM
From: Robert Knight  Read Replies (3) | Respond to of 1510
 
What do you make of the new short interest numbers on IMNR? I remember you scoffing at my suggesting that IMNR was being shorted....

4,395,755 shares reported short for 7/98 compared to 1,773,794 shares for 6/98. An increase of 2,621,961 shorted shares or 150% increase over the prior month!

I sure wish I could create 2.6 million shares of "artificial" buying so I could move the stock higher....<g>

Robert